Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tamoxifen Versus Estradiol in the Prevention of Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Controlled Pilot Trial

NCT04933240 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT04933240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04933240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tamoxifen Versus Estradiol in the Prevention of Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Controlled Pilot Trial
Lead sponsor
Virginia Commonwealth University
Phase
Phase 4
Overall status
Withdrawn
Start date
May 31, 2022
Completion date
December 31, 2024
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

vaginal bleeding